« Back
Home /
Mobocertinib (succinate)

Mobocertinib (succinate)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	100 mg
Quantity options	100 mg 10mM/1mL 10 mg 25 mg 500 mg 50 mg 5 mg
Item no.	HY-135815A-100mg
Targets	EGFR
CASRN	2389149-74-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Alias	TAK-788 (succinate); AP32788 (succinate)
Purity	99.61
Product Description	Mobocertinib (TAK-788) succinate is an orally active and irreversible EGFR/HER2 inhibitor. Mobocertinib succinate potently inhibits oncogenic variants containing activating EGFRex20ins mutations with selectivity over wild-type EGFR. Mobocertinib succinate can be used in NSCLC research[1][2].
StorageTemperature	4°C (Powder, sealed storage, away from moisture)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	703.78
Clinical_Information	Launched
Manufacturers Research Area	Cancer
Solubility	DMSO : 125 mg/mL (ultrasonic)
Manufacturers Target	EGFR
Isoform	EGFR/ErbB1/HER1; ErbB2/HER2
Pathway	JAK/STAT Signaling; Protein Tyrosine Kinase/RTK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Request delivery time